Covid-19: See latest data on suppliers and inventory

SANOFI U.S. logo

SANOFI U.S.

PSF Verified
55 Corporate Drive, Bridgewater, NJ 08807, United States
Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health, and the new G enzyme. Its products include prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines, and other medical products. The...
DUNS #:
824676584
CAGE Code:
6TXG7
Type:
Manufacturer
Employees:
More than 100,000
Annual Revenue:
More than $10B
Year Founded:
2004
Country of Origin:
United States
Sectors Served:
US Federal, US State, US Local, Private Sector, Non-US Public Sector
Company Security Level:
Unknown
Credit Card Usage:
Unknown

Specialties and Expertise:

Vaccines, Pediatric Vaccines, Polio Injectable Vaccines, Severe Acute Respiratory Syndrome (SARS) Vaccine, Vaccine Candidate, Yellow Fever Vaccine Information, Adjuvanted Recombinant Vaccine Produ...

COVID-19 Supplies1

Are you making PPE or ventilators for COVID-19?
Let us know
Categories
Products Available
Inventory/Capacity
Certification
Available Contracts
Contact Info
Vaccines and Therapeutics
Kevzara
no data
no data
no data
no data

Contact Info3

Size and minority status

Size
Other than small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Commodity Codes8

PRODUCTS AND SERVICES4

Prescription and Over-the-Counter Drugs
Sanofi provides prescription and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, Respiratory and inflammatory diseases, vaccines, and rheumatic diseases.
Sanofi R&D
Sanofi's major research and development areas are Oncology, Immunology & Inflammation, Rare Blood Disorders, Rare and Neurologic Diseases, Diabetes & Cardiovascular (DCV), and Vaccines.
Flublok Quadrivalent Influenza Vaccine
Flublok Quadrivalent is a vaccine for the prevention of influenza disease caused by influenza A and B given to people 18 years of age and older.
Kevzara
Kevzara is a fully-human monoclonal antibody for rheumatoid arthritis that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor. The med is on clinical trails to combat Covid-19 coronavirus infection.

Past experience2

other
Influenza Vaccine and COVID-19 program
Sanofi has entered into an agreement with BARDA to establish facilities in the US for the production of an adjuvanted recombinant va...
other
Kevzara to treat severe COVID-19
Sanofi and Regeneron Pharmaceuticals have started a clinical trial program evaluating Kevzara a rheumatoid arthritis drug to treat h...

Existing Contracts1

Contract Vehicle Type
Contract Name
Contract #
Who Can Use
Managing Organization
Exp. Date
no data
no data
V797D-70230
Federal
US General Services Administration (GSA)
Sep 14, 2022

External Recognition1

Corporate Social Responsibility (CSR) Recognition
Sanofi U.S. distinguished for 10th consecutive year in field of Corporate Social Responsibility (...

Locations served1

  • United States 3 locations
My Notes
Contact
My Notes